Merck Canada Inc.
Records under this name other than the patents Merck Canada Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 16 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,518,964 | Tricyclic Compounds Useful as Inhibitors of Kinases Formerly held In force · High confidence | In force | High confidence | |
| US 9,023,864 | Indole Derivatives as CRTH2 Receptor Antagonists Formerly held In force · High confidence | In force | High confidence | |
| US 8,394,819 | Indole Derivatives as CRTH2 Receptor Antagonists Formerly held In force · High confidence | In force | High confidence | |
| US 9,145,391 | Bipyridylaminopyridines as Syk Inhibitors Formerly held In force · High confidence | In force | High confidence | |
| US 9,328,138 | HCV NS3 Protease Inhibitors Formerly held In force · High confidence | In force | High confidence | |
| US 9,376,418 | Substituted Pyridine Spleen Tyrosine Kinase (SYK) Inhibitors Formerly held In force · High confidence | In force | High confidence | |
| US 9,487,504 | Imidazolyl Analogs as Syk Inhibitors Formerly held In force · High confidence | In force | High confidence | |
| US 8,987,195 | HCV NS3 Protease Inhibitors Formerly held In force · High confidence | In force | High confidence | |
| US 9,353,066 | Substituted Phenyl-Spleen Tyrosine Kinase (SYK) Inhibitors Formerly held In force · High confidence | In force | High confidence | |
| US 9,586,931 | Triazolyl Derivatives as Syk Inhibitors Formerly held In force · High confidence | In force | High confidence |